Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells

Dong-Jun Fua Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of ChinaView further author information

Si-Meng Liub Department of Gastroenterology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information

Jia-Jia Yangc Department of Pharmacy, People’s Hospital of Zhengzhou, Zhengzhou, People’s Republic of ChinaView further author information

Jun Lia Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0001-8243-5267 View further author information

Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date